ten23 health Valais AG

Visp, SwitzerlandFEI 3014757826

ten23 health Valais AG is a drug establishment in Visp, Switzerland, registered with the US FDA under FEI 3014757826. Its registered operations are: Drug manufacture. 12 EU/UK GMP certificates are matched to this site, 6 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Drug manufacture

GMP documents matched to this site (12)

DocumentAuthorityInspectionSource
GMPE-CH-11008500
GMP certificate
Competent authority of Switzerland25 Mar 2026
within 3-year review window
EudraGMDP
GMPE-CH-1008499
GMP certificate
Competent authority of Switzerland25 Mar 2026
within 3-year review window
EudraGMDP
GMPE-CH-1007523
GMP certificate
Competent authority of Switzerland17 Apr 2025
within 3-year review window
EudraGMDP
GMPE-CH-1007524
GMP certificate
Competent authority of Switzerland17 Apr 2025
within 3-year review window
EudraGMDP
GMPE-CH-1008649
GMP certificate
Competent authority of Switzerland17 Apr 2025
within 3-year review window
EudraGMDP
GMPE-CH-1008650
GMP certificate
Competent authority of Switzerland17 Apr 2025
within 3-year review window
EudraGMDP
GMPE-CH-1004849
GMP certificate
Competent authority of Switzerland17 May 2023
outside 3-year review window
EudraGMDP
GMPE-CH-1006939
GMP certificate
Competent authority of Switzerland17 May 2023
outside 3-year review window
EudraGMDP
GMPE-CH-1007393
GMP certificate
Competent authority of Switzerland17 May 2023
outside 3-year review window
EudraGMDP
GMPE-CH-1004850
GMP certificate
Competent authority of Switzerland14 Oct 2022
outside 3-year review window
EudraGMDP
GMPE-CH-1006938
GMP certificate
Competent authority of Switzerland14 Oct 2022
outside 3-year review window
EudraGMDP
GMPE-CH-1007392
GMP certificate
Competent authority of Switzerland14 Oct 2022
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.

Other sites registered by the same company